Published in Endocrinology on August 01, 1990
Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol (1993) 1.64
Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest (1993) 1.13
Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells. J Clin Invest (1991) 1.01
Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. J Clin Invest (1990) 0.81
Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site. Antimicrob Agents Chemother (1986) 2.72
Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis (1985) 2.32
Glucose intolerance in cystic fibrosis. N Engl J Med (1969) 1.85
Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A (1993) 1.85
Leuconostoc, an emerging vancomycin-resistant pathogen. Lancet (1987) 1.80
Alterations in kinetic properties of penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1986) 1.76
Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. J Infect Dis (1986) 1.71
Tuberculosis and the acquired immunodeficiency syndrome at a New York City hospital: 1978-1985. Chest (1987) 1.67
Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol (1993) 1.64
Oxygen tension directs the differentiation pathway of human cytotrophoblast cells. Placenta (2007) 1.63
Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob Agents Chemother (1995) 1.61
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A (1987) 1.57
Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts. Nature (1983) 1.51
Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid. Gene (1996) 1.47
Intracellular population genetics: evidence for random drift of mitochondrial allele frequencies in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genetics (1980) 1.35
Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genomics (2001) 1.35
Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology (2000) 1.25
An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. J Biol Chem (1987) 1.21
Forkhead transcription factor FOXO1A is critical for induction of human decidualization. J Endocrinol (2006) 1.19
Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine (1997) 1.17
Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Commun (1988) 1.14
A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem (1993) 1.13
Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem (2000) 1.12
Glycine-directed peptide amidation: presence in rat brain of two enzymes that convert p-Glu-His-Pro-Gly-OH into p-Glu-His-Pro-NH2 (thyrotropin-releasing hormone). Proc Natl Acad Sci U S A (1984) 1.09
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci. Antimicrob Agents Chemother (1992) 1.08
Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res (1995) 1.05
Conjugative mobilization of a vancomycin resistance plasmid by a putative Enterococcus faecium sex pheromone response plasmid. Microb Drug Resist (1995) 1.05
Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab (1992) 1.04
Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology (1990) 1.04
Nonenzymatic peptide alpha-amidation. Implications for a novel enzyme mechanism. J Biol Chem (1985) 1.03
Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J Cell Biochem (1992) 1.02
Antibiotic tolerance among clinical isolates of bacteria. Annu Rev Pharmacol Toxicol (1985) 1.02
Microarray analysis of trophoblast differentiation: gene expression reprogramming in key gene function categories. Physiol Genomics (2001) 1.01
Peptidoglycan composition of vancomycin-resistant Enterococcus faecium. Microb Drug Resist (1996) 1.00
Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science (1978) 1.00
MMPs are IGFBP-degrading proteinases: implications for cell proliferation and tissue growth. Ann N Y Acad Sci (1999) 0.99
Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem (1992) 0.98
Amino-acid sequence of human placental lactogen. Nat New Biol (1971) 0.98
Prostaglandin E2 enhances human endometrial stromal cell differentiation. Endocrinology (1994) 0.98
Regulation of the human chorionic gonadotropin alpha- and beta-subunit promoters by AP-2. J Biol Chem (1997) 0.97
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol (1995) 0.97
Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3. Endocrinology (1994) 0.96
An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression. J Mol Endocrinol (2002) 0.96
Activator protein-2 regulates human placental lactogen gene expression. Mol Cell Endocrinol (2000) 0.96
Ovine placental lactogen induces somatomedin: a a possible role in fetal growth. Endocrinology (1977) 0.96
Differential localization of heat shock proteins 90, 70, 60 and 27 in human decidua and placenta during pregnancy. Histochem J (1998) 0.96
Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. J Clin Invest (1997) 0.95
Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab (1991) 0.95
Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. J Biol Chem (1993) 0.94
Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology (1995) 0.94
Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology (1994) 0.94
Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology (1997) 0.93
Binding studies of vancomycin to the cytoplasmic peptidoglycan precursors by affinity capillary electrophoresis. Anal Chem (1994) 0.92
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria. J Antimicrob Chemother (1997) 0.91
Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Endocrinology (1992) 0.91
Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem (1990) 0.90
Differential expression of AP-2gamma and AP-2alpha during human trophoblast differentiation. Life Sci (2001) 0.90
Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1996) 0.89
Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia. Endocrinology (2007) 0.89
Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J Biol Chem (1996) 0.89
Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma human placental lactogen concentrations and fetal growth. J Clin Endocrinol Metab (1988) 0.89
Peritoneal fluid prolactin in infertile women with endometriosis: lack of evidence of secretory activity by endometrial implants. Fertil Steril (1984) 0.88
Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell (1998) 0.87
Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res (1995) 0.86
Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro. J Clin Endocrinol Metab (1979) 0.86
Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4. J Biol Chem (1995) 0.86
Thyroiditis due to Mycobacterium chelonei. Am Rev Respir Dis (1974) 0.86
Characterization of the synthesis and release of prolactin by an enriched fraction of human decidual cells. J Clin Endocrinol Metab (1983) 0.85
Interleukin-1 beta and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod (1995) 0.85
Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Mol Endocrinol (2001) 0.85
Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology (1991) 0.84
Isolation and structural characterization of ovine placental lactogen. Biochemistry (1977) 0.84
Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem (1995) 0.84
Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology (1994) 0.84
High density lipoproteins stimulate placental lactogen release and adenosine 3',5'-monophosphate (cAMP) production in human trophoblast cells: evidence for cAMP as a second messenger in human placental lactogen release. Endocrinology (1988) 0.84
Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. Endocrinology (1998) 0.84
Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery (1994) 0.83
Bovine serum albumin-GABA-His-Pro-NH2: an immunogen for production of higher affinity antisera for TRH. J Neurosci Methods (1983) 0.83
Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann N Y Acad Sci (1993) 0.82
Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts. J Cell Physiol (1994) 0.82
Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells. Mol Pharmacol (1985) 0.82
Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding. Endocrinology (1993) 0.82
Differential synthesis of human placental lactogen and human chorionic gonadotropin in vitro. Endocrinology (1978) 0.82
Ovine placental lactogen stimulates glycogen synthesis in fetal rat hepatocytes. Am J Physiol (1984) 0.82
The direct in vitro effect of insulin-like growth factors (IGFs) on normal bovine mammary cell proliferation and production of IGF binding proteins. Endocrinology (1991) 0.82
Synthesis of prolactin by human decidua in vitro. J Endocrinol (1979) 0.82
Purification and characterization of a peptidyl glycine monooxygenase from porcine pituitary. Endocrinology (1986) 0.82
Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type). Growth Horm IGF Res (2007) 0.82
A unique placental lactogen receptor: implications for fetal growth. Endocrinology (1987) 0.82
A rapid, sensitive assay for glycine-directed amidating enzymes. J Neurosci Methods (1985) 0.81
Laminin decreases PRL and IGFBP-1 expression during in vitro decidualization of human endometrial stromal cells. J Cell Physiol (1995) 0.81
Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism. World J Surg (1987) 0.81
Studies on ovine placental lactogen secretion by homologous radioimmunoassay. J Endocrinol (1977) 0.81
Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. J Clin Invest (1990) 0.81
Synergistic effects of oPL and insulin on glycogen metabolism in fetal rat hepatocytes. Am J Physiol (1984) 0.81
Somatomedin-C stimulates glycogen synthesis in fetal rat hepatocytes. Endocrinology (1985) 0.81
Serum immunoreactive somatomedin-C is elevated late in pregnancy. J Clin Endocrinol Metab (1978) 0.81
Listeria monocytogenes: a rare cause of opportunistic infection in the acquired immunodeficiency syndrome (AIDS) and a new cause of meningitis in AIDS. A case report. AIDS Res (1986) 0.81